|
1
|
de Alwis NM and Day CP: Non-alcoholic
fatty liver disease: the mist gradually clears. J Hepatol.
48:S104–S112. 2008.PubMed/NCBI
|
|
2
|
Angulo P, Keach JC, Batts KP and Lindor
KD: Independent predictors of liver fibrosis in patients with
nonalcoholic steatohepatitis. Hepatology. 30:1356–1362. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Matteoni CA, Younossi ZM, Gramlich T, et
al: Non-alcoholic fatty liver disease: a spectrum of clinical and
pathological severity. Gastroenterology. 116:1413–1419. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Teli MR, James OF, Burt AD, et al: The
natural history of non-alcoholic fatty liver: a follow-up study.
Hepatology. 22:1714–1719. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Day CP and James OFW: Steatohepatitis: a
tale of two ‘hits’? Gastroenterology. 114:842–845. 1998.
|
|
6
|
Cortez-Pinto H, de Moura MC and Day CP:
Non-alcoholic steatohepatitis: from cell biology to clinical
practice. J Hepatol. 44:197–208. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen CH, Huang MH, Yang JC, et al:
Prevalence and risk factors of nonalcoholic fatty liver disease in
an adult population of Taiwan: metabolic significance of
nonalcoholic fatty liver disease in nonobese adults. J Clin
Gastroenterol. 40:745–752. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bellentani S, Saccoccio G, Masutti F, et
al: Prevalence of and risk factors for hepatic steatosis in
Northern Italy. Ann Intern Med. 132:112–117. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shen L, Fan JG, Shao Y, et al: Prevalence
of nonalcoholic fatty liver among administrative officers in
Shanghai: an epidemiological survey. World J Gastroenterol.
9:1106–1110. 2003.PubMed/NCBI
|
|
10
|
Angulo P: Nonalcoholic fatty liver
disease. N Engl J Med. 346:1221–1231. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bugianesi E, McCullough AJ and Marchesini
G: Insulin resistance: a metabolic pathway to chronic liver
disease. Hepatology. 42:987–1000. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
McCullough AJ: Update on non-alcoholic
fatty liver disease. J Clin Gastroenterol. 34:255–262. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lawrence T, Gilroy DW, Colville-Nash PR
and Willoughby DA: Possible new role for NF-κB in the resolution of
inflammation. Nat Med. 7:1291–1297. 2001.
|
|
14
|
Riehemann K, Behnke B and Schulze-Osthoff
K: Plant extracts from stinging nettle (Urtica dioica), an
antirheumatic remedy, inhibit the proinflammatory transcription
factor NF-κB. FEBS Lett. 442:89–94. 1999.PubMed/NCBI
|
|
15
|
Renard P and Raes M: The proinflammatory
transcription factor NF-kappaB: a potential target for novel
therapeutical strategies. Cell Biol Toxicol. 15:341–344. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Makarov SS: NF-κB as a therapeutic target
in chronic inflammation: recent advances. Mol Med Today. 6:441–448.
2000.
|
|
17
|
Ywsilada E, Ustun O, Sezik E, et al:
Inhibitory effect of Turkish folk remedies on inflammatory
cytokines: interleukin-1α, interleukin-1β and tumor necrosis factor
α. J Ethnopharmacol. 58:59–73. 1997.PubMed/NCBI
|
|
18
|
Costantino L, Albasini A, Rastelli G and
Benvenuti S: Activity of polyphenolic crude extracts as scavengers
of superoxide radicals and inhibitors of xanthine oxidase. Planta
Med. 58:342–344. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang SY and Lin HS: Antioxidant activity
in fruits and leaves of blackberry, raspberry, and strawberry
varies with cultivar and development stage. J Agric Food Chem.
48:140–146. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Alonso R, Cadavid I and Calleja JM: A
preliminary study of hypoglycemic activity of Rubus
fruticosus. Planta Med. 7(Suppl): S102–S106. 1980. View Article : Google Scholar
|
|
21
|
Lee JH, Ham YA, Choi SH, et al: Activity
of crude extract of Rubus crataegifolius roots as a potent
apoptosis inducer and DNA topoisomerase I inhibitor. Arch Pharm
Res. 23:338–343. 2000.
|
|
22
|
Rauha JP, Remes S, Heinonen M, et al:
Antimicrobial effects of Finnish plant extracts containing
flavonoids and other phenolic compounds. Int J Food Microbiol.
56:3–12. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hong ZF, Li TJ and Zhao JY: Effect of
total alkaloids of Rubus aleaefolius Poir on gene
expressions of CYP2E2 and CYP3A1 in rats with acute liver injury.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 29:711–715. 2009.(In
Chinese).
|
|
24
|
Lin JM, Zhao JY, Li TJ, et al:
Hepatoprotection in a rat model of acute liver damage through
inhibition of CY2E1 activity by total alkaloids extracted from
Rubus alceifolius Poir. Int J Toxicol. 30:237–243. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Brunt EM: Nonalcoholic steatohepatitis:
pathologic features and differential diagnosis. Semin Diagn Pathol.
22:330–338. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bellentani S and Tiribelli C: The spectrum
of liver disease in the general population: lesson from the
Dionysos study. J Hepatol. 35:531–537. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Brunt EM: Pathology of nonalcoholic
steatohepatitis. Hepatol Res. 33:68–71. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Farrell GC and Larter CZ: Nonalcoholic
fatty liver disease: from steatosis to cirrhosis. Hepatology.
43(Suppl 1): S99–S112. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ye HZ, Hong ZF, Wang YH and Chen YH:
Effects of crude extract of Rubus Alcaefolius Poir on
experimental liver injury in rats. Chin Arch Tradit Chin Med.
23:829–831. 2005.
|
|
30
|
Yamaguchi K, Yang L, McCall S, et al:
Inhibiting triglyceride synthesis improves hepatic steatosis but
exacerbates liver damage and fibrosis in obese mice with
nonalcoholic steatohepatitis. Hepatology. 45:1366–1374. 2007.
View Article : Google Scholar
|
|
31
|
Bonizzi G and Karin M: The two NF-kappaB
activation pathways and their role in innate and adaptive immunity.
Trends Immunol. 25:280–288. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Baldwin AS Jr: The NF-kappaB and I-kappaB
proteins: new discoveries and insights. Annu Rev Immunol.
14:649–683. 1996. View Article : Google Scholar : PubMed/NCBI
|
